News

Angiography demonstrates a high-grade, modestly angulated stenosis (arrow) in the proximal segment of a large diagonal branch (A). Predilation performed with difficulty, and the GEC could not be advanced beyond stenosis even with “inch worming” techniques. (B). Advancement of the CrossFAST (C) beyond the proximal stent edge stenosis (a.), the position of the distal end of the outer catheter (b.), and the microcatheter tip (c.) are indicated.

The CrossFAST system was successfully used to deploy multiple stents after other devices fell short. 

heart surgery surgeons

The American Association for Thoracic Surgery has announced a new partnership with the Cardiothoracic Surgical Trials Network. The groups plan on working together to address current challenges in cardiothoracic surgery research.

Newsweek ranked the 50 best heart hospitals in the world

Oversizing transcatheter heart valves can improve TAVR outcomes. There is still a reason to be cautious, however, especially when patients are receiving a balloon-expandable valve.

Semaglutide, the GLP-1 receptor agonist sold by Novo Nordisk under the brand names Wegovy and Ozempic, is associated with significant health benefits for patients with type 2 diabetes and peripheral artery disease (PAD), according to a late-breaking clinical trial presented at ACC.25, the annual meeting of the American College of Cardiology (ACC).

The American College of Cardiology's 2026 annual meeting will include an all-time record of 60 late-breaking clinical studies.

Kit Crancer, chair of the Radiology Business Management Association Radiology (RBMA) Patient Action Network, and senior vice president of public policy for Rayus, explains RBMA's concerns over how the Trump administration's $1 trillion in cuts to Medicaid will economically impact rural hospitals.

"It is almost a tidal wave of change from the federal level that is going to begin impacting state legislatures across the country. I think folks should probably be aware of that,” said RBMA's Kit Crancer. 

claude anthropic

Ben White, MD, believes Dario Amodei may have “set a new record on how quickly you can be wrong about how radiology works and how it’s been affected by AI so far.”

U.S. FDA Sign

The country’s largest imaging group announced the news March 5, with the decision applying to its Cognita Chest X-ray tool across multiple clinical indications. 

artificial intelligence in healthcare

Unlike many stroke detection applications on the market, this model covers six vascular territories and mechanisms of infarct. 

Philips has secured U.S. Food and Drug Administration (FDA) clearance for SmartHeart, the company’s new artificial intelligence (AI)-powered planning technology for cardiac MR (CMR) exams.

The new SmartHeart technology automates 14 cardiac views in less than 30 seconds. It was designed to increase productivity and bring more consistency to cardiology and radiology departments.

FDA issues recall of imaging systems

Back in February, the FDA expanded a recall of several reprocessed EP and ultrasound catheters due to a risk of contamination. The agency is now sharing additional information with the public.

Stanford and Rad Partners recently developed a structured, pre-deployment method for assessing radiology AI models, detailing their work in the American Journal of Roentgenology. 

money education graduate cap

In January, the Department of Education released a proposed rule seeking to simplify federal student loan repayment, including "commonsense loan caps" and "streamlining repayment options." 

Around the web

The CrossFAST system was successfully used to deploy multiple stents after other devices fell short.